These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA. Moalli PA, Pillay S, Weiner D, Leikin R, Rosen ST. Blood; 1992 Jan 01; 79(1):213-22. PubMed ID: 1728309 [Abstract] [Full Text] [Related]
4. Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma. Thomas AL, Coarfa C, Qian J, Wilkerson JJ, Rajapakshe K, Krett NL, Gunaratne PH, Rosen ST. Nucl Recept Signal; 2015 Jan 01; 13():e006. PubMed ID: 26715915 [Abstract] [Full Text] [Related]
5. Glucocorticoid receptor transcriptional isoforms and resistance in multiple myeloma cells. Sánchez-Vega B, Krett N, Rosen ST, Gandhi V. Mol Cancer Ther; 2006 Dec 01; 5(12):3062-70. PubMed ID: 17172408 [Abstract] [Full Text] [Related]
6. Cortivazol mediated induction of glucocorticoid receptor messenger ribonucleic acid in wild-type and dexamethasone-resistant human leukemic (CEM) cells. Ashraf J, Kunapuli S, Chilton D, Thompson EB. J Steroid Biochem Mol Biol; 1991 May 01; 38(5):561-8. PubMed ID: 2039752 [Abstract] [Full Text] [Related]
7. Interleukin-6-independent expression of glucocorticoid receptor is upregulated by triptolide in multiple myeloma. Yang M, Shen JK, Huang J, Du HP, Ma QL, Jin J. Leuk Lymphoma; 2009 May 01; 50(5):802-8. PubMed ID: 19330649 [Abstract] [Full Text] [Related]
8. Regulation of glucocorticoid receptor expression in cultured fibroblasts from a patient with familial glucocorticoid resistance. Brönnegård M, Werner S, Gustafsson JA. J Steroid Biochem Mol Biol; 1991 Nov 01; 39(5A):693-701. PubMed ID: 1659867 [Abstract] [Full Text] [Related]
10. Crosstalk between glucocorticoid and mineralocorticoid receptors boosts glucocorticoid-induced killing of multiple myeloma cells. Clarisse D, Prekovic S, Vlummens P, Staessens E, Van Wesemael K, Thommis J, Fijalkowska D, Acke G, Zwart W, Beck IM, Offner F, De Bosscher K. Cell Mol Life Sci; 2023 Aug 14; 80(9):249. PubMed ID: 37578563 [Abstract] [Full Text] [Related]
11. Dexamethasone-induced apoptotic mechanisms in myeloma cells investigated by analysis of mutant glucocorticoid receptors. Sharma S, Lichtenstein A. Blood; 2008 Aug 15; 112(4):1338-45. PubMed ID: 18515658 [Abstract] [Full Text] [Related]
12. Screening of an annotated compound library for drug activity in a resistant myeloma cell line. Rickardson L, Fryknäs M, Haglund C, Lövborg H, Nygren P, Gustafsson MG, Isaksson A, Larsson R. Cancer Chemother Pharmacol; 2006 Dec 15; 58(6):749-58. PubMed ID: 16528529 [Abstract] [Full Text] [Related]
13. A variant glucocorticoid receptor messenger RNA is expressed in multiple myeloma patients. Krett NL, Pillay S, Moalli PA, Greipp PR, Rosen ST. Cancer Res; 1995 Jul 01; 55(13):2727-9. PubMed ID: 7796394 [Abstract] [Full Text] [Related]
14. Glucocorticoid-resistant lymphoma cell variants that contain functional glucocorticoid receptors. Rabindran SK, Danielsen M, Stallcup MR. Mol Cell Biol; 1987 Dec 01; 7(12):4211-7. PubMed ID: 2830485 [Abstract] [Full Text] [Related]
15. Glucocorticoid resistance in a multiple myeloma cell line is regulated by a transcription elongation block in the glucocorticoid receptor gene (NR3C1). Sánchez-Vega B, Gandhi V. Br J Haematol; 2009 Mar 01; 144(6):856-64. PubMed ID: 19133980 [Abstract] [Full Text] [Related]
16. Dexamethasone-induced cell death is restricted to specific molecular subgroups of multiple myeloma. Kervoëlen C, Ménoret E, Gomez-Bougie P, Bataille R, Godon C, Marionneau-Lambot S, Moreau P, Pellat-Deceunynck C, Amiot M. Oncotarget; 2015 Sep 29; 6(29):26922-34. PubMed ID: 26323097 [Abstract] [Full Text] [Related]
17. Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis. Thompson EB, Nazareth LV, Thulasi R, Ashraf J, Harbour D, Johnson BH. J Steroid Biochem Mol Biol; 1992 Mar 29; 41(3-8):273-82. PubMed ID: 1314075 [Abstract] [Full Text] [Related]
18. Effects of Dexamethasone on glucocorticoid receptor expression in a human ovarian carcinoma cell line 3AO. Xu M, Song L, Wang Z. Chin Med J (Engl); 2003 Mar 29; 116(3):392-5. PubMed ID: 12781044 [Abstract] [Full Text] [Related]
19. Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma. Zhao JJ, Chu ZB, Hu Y, Lin J, Wang Z, Jiang M, Chen M, Wang X, Kang Y, Zhou Y, Ni Chonghaile T, Johncilla ME, Tai YT, Cheng JQ, Letai A, Munshi NC, Anderson KC, Carrasco RD. Cancer Res; 2015 Oct 15; 75(20):4384-4397. PubMed ID: 26249174 [Abstract] [Full Text] [Related]
20. Pomalidomide in combination with dexamethasone results in synergistic anti-tumour responses in pre-clinical models of lenalidomide-resistant multiple myeloma. Rychak E, Mendy D, Shi T, Ning Y, Leisten J, Lu L, Miller K, Narla RK, Orlowski RZ, Raymon HK, Bjorklund CC, Thakurta A, Gandhi AK, Cathers BE, Chopra R, Daniel TO, Lopez-Girona A. Br J Haematol; 2016 Mar 15; 172(6):889-901. PubMed ID: 26914976 [Abstract] [Full Text] [Related] Page: [Next] [New Search]